BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27100101)

  • 1. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
    Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
    Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
    Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
    Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
    Aoun M; Makki M; Azar H; Matta H; Chelala DN
    BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desphospho-uncarboxylated matrix Gla-protein is associated with mortality risk in patients with chronic stable vascular disease.
    Mayer O; Seidlerová J; Bruthans J; Filipovský J; Timoracká K; Vaněk J; Cerná L; Wohlfahrt P; Cífková R; Theuwissen E; Vermeer C
    Atherosclerosis; 2014 Jul; 235(1):162-8. PubMed ID: 24835435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
    Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of kidney transplantation and phosphate binder use in vitamin K status.
    Jansz TT; Neradova A; van Ballegooijen AJ; Verhaar MC; Vervloet MG; Schurgers LJ; van Jaarsveld BC
    PLoS One; 2018; 13(8):e0203157. PubMed ID: 30161193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based Study.
    Pivin E; Ponte B; Pruijm M; Ackermann D; Guessous I; Ehret G; Liu YP; Drummen NE; Knapen MH; Pechere-Bertschi A; Paccaud F; Mohaupt M; Vermeer C; Staessen JA; Vogt B; Martin PY; Burnier M; Bochud M
    Hypertension; 2015 Jul; 66(1):85-92. PubMed ID: 25987667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K status and mortality after kidney transplantation: a cohort study.
    Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
    Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
    Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
    Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
    Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
    PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies.
    Wei FF; Drummen NE; Schutte AE; Thijs L; Jacobs L; Petit T; Yang WY; Smith W; Zhang ZY; Gu YM; Kuznetsova T; Verhamme P; Allegaert K; Schutte R; Lerut E; Evenepoel P; Vermeer C; Staessen JA
    EBioMedicine; 2016 Feb; 4():162-9. PubMed ID: 26981580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report.
    Schurgers LJ; Barreto DV; Barreto FC; Liabeuf S; Renard C; Magdeleyns EJ; Vermeer C; Choukroun G; Massy ZA
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):568-75. PubMed ID: 20133489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating matrix Gla protein is associated with coronary artery calcification and vitamin K status in healthy women.
    Dalmeijer GW; van der Schouw YT; Vermeer C; Magdeleyns EJ; Schurgers LJ; Beulens JW
    J Nutr Biochem; 2013 Apr; 24(4):624-8. PubMed ID: 22819559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of menaquinone-7 supplementation on circulating species of matrix Gla protein.
    Dalmeijer GW; van der Schouw YT; Magdeleyns E; Ahmed N; Vermeer C; Beulens JW
    Atherosclerosis; 2012 Dec; 225(2):397-402. PubMed ID: 23062766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients.
    Fain ME; Kapuku GK; Paulson WD; Williams CF; Raed A; Dong Y; Knapen MHJ; Vermeer C; Pollock NK
    Am J Hypertens; 2018 May; 31(6):735-741. PubMed ID: 29635270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desphospho-uncarboxylated matrix Gla protein is a novel circulating biomarker predicting deterioration of renal function in the general population.
    Wei FF; Trenson S; Thijs L; Huang QF; Zhang ZY; Yang WY; Moliterno P; Allegaert K; Boggia J; Janssens S; Verhamme P; Vermeer C; Staessen JA
    Nephrol Dial Transplant; 2018 Jul; 33(7):1122-1128. PubMed ID: 28992263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between uncarboxylated matrix Gla protein and lipoprotein-associated phospholipase A2.
    Mayer O; Seidlerová J; Vaněk J; Kielbergerová L; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Trefil L; Knapen MH; Drummen NE; Vermeer C
    Maturitas; 2015 Jan; 80(1):82-8. PubMed ID: 25458708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.